- Coeptis received Nasdaq clearance for post-merger common stock listing on Nasdaq Global Market under ticker ZSQR, effective at merger close.
- Listing change ties to planned merger with Z Squared, which would become wholly owned subsidiary; Coeptis would rename to Z Squared.
- Transaction still awaits remaining customary closing conditions; closing expected in Q2 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coeptis Therapeutics Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604071205PRIMZONEFULLFEED9685420) on April 07, 2026, and is solely responsible for the information contained therein.
Comments